Medical Countermeasures Nanoparticle Anthrax Vaccine Shows Promise in Enhancing Biodefense PreparednessGlobal Biodefense StaffSeptember 9, 2025
Medical Countermeasures New Mutation and DNA Repeats Behind Ceftazidime Resistance in Melioidosis BacteriumGlobal Biodefense StaffSeptember 5, 2025
Medical Countermeasures Appili Therapeutics Reports Strong Preclinical Protection from ATI-1701 Tularemia VaccineGlobal Biodefense StaffAugust 11, 2025
NanoViricides Confirms It Has Been Working On Treatment for Novel Coronavirus Medical Countermeasures January 30, 2020 …
Inovio, Beijing Advaccine Collaborate to Advance INO-4800 Vaccine Medical Countermeasures January 30, 2020 …
AbCellera is Mobilizing a Response to the Novel Coronavirus Outbreak as Part of its DARPA P3 Program Medical Countermeasures January 29, 2020 …
Sirnaomics Advances RNAi-Based Prophylactics and Therapeutics to Battle SARI Caused by 2019-nCoV Medical Countermeasures January 24, 2020 …
CEPI to Fund Development of Multiple Candidate Vaccines Against the Novel Coronavirus Medical Countermeasures January 23, 2020 …
Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus Medical Countermeasures January 23, 2020 …
Revocation of Emergency Use Authorizations of Zika, Ebola Diagnostics Medical Countermeasures January 12, 2020 …
Emory University to Lead Infectious Diseases Clinical Research Consortium Leadership Group Medical Countermeasures January 3, 2020 …
Investigational Drugs Reduce Risk of Death from Ebola Virus Disease Medical Countermeasures December 2, 2019 …
Phase 3 Trial of Modified Vaccinia Ankara as a Smallpox Vaccine Medical Countermeasures November 14, 2019 …
Carb-X Funds Techulon’s Rapidly Adaptable Nano Therapeutic in Fight Against Drug Resistant Bacteria Antimicrobial Resistance November 11, 2019 …
Atriva Therapeutics Reports Results of Phase I Clinical Trial for ATR-002 Antiviral Industry News November 8, 2019 …
Highly Diluted Dose of Ebola Vaccine Shown Effective in Primate Study Medical Countermeasures October 20, 2019 …
Bavarian Nordic Announces Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine Medical Countermeasures October 10, 2019 …
Radiation Poisoning Countermeasure May Also Protect Against MRI Contrast Agent Toxicity CBRNE October 10, 2019 …
